ArticleOncoimmunology2024

Multiprong CD38 targeting to enhance anti-PD1 immune checkpoint blockade efficacy.

Vishnu Vijay Vijayan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.